Events
Industry Conferences & Events
Attend IHI's Patient Safety Program where you'll develop detailed, customized patient safety strategies and implementation plans.
[More]
Participate in discussion on ways to apply the role of epidemiology and risk management, from both industry and FDA perspectives.
[More]
Assessing and Managing Risk from Preclinical Testing through Clinical Trials to Post-Approval & Marketing in the US & Abroad
[More]
CBI has successfully built and maintained a franchise in the Post-Approval space with unmatched research and industry admired speakers and continues that tradition for 2010!
[More]
Join Authorities, Global Regulators, Industry Representatives, and Marketing Application Holders for an Interactive Discussion of RMPs.
[More]
Joint DIA/EFGCP Pharmacovigilance Audit and Inspection - Opportunities for Patient Safety
October 1, 2010 London, UKThis workshop aims to provide a neutral platform for regulators and industry to jointly review experience from pharmacovigilance audits and inspections across national boundaries
[More]
Development of Type 2 Diabetes Mellitus Drugs: State of the Art Cardiovascular Safety Assessments
October 5 - 6, 2010 Washington, DCInteract with Senior FDA Members to Explore Emerging Issues in Cardiovascular Safety and Diabetic Drug Development.
[More]
Join Leaders from Industry, Academia, CDC, FDA, EMA, and WHO to Discuss Emerging Topics in Maternal and Pediatric Drug Safety.
[More]
CBI is proud to expand on its drug safety series with the inaugural Safety Assessment of Serious Adverse Events in CNS.
[More]
A one-of-its kind conference exploring effective risk management to improve drug safety and protect consumers’ well-being
[More]
Ensuring Quality and Balancing Risks for Multiregional Clinical Trials: Statistical, Clinical, Regulatory, and Ethical Factors
October 26 - 27, 2010 Bethesda, MDJoin Industry and International Regulatory Leaders to Address Multiregional Clinical Trial Opportunities and Risks from a Global Perspective
[More]
This conference aims to contribute to the further advancement of international clinical development by deepening the mutual understanding among those working in the pharmaceutical industry, academia and regulatory authorities.
[More]
DIA's 8th Annual Canadian Meeting: Fostering Innovation and Access to Drugs in Canada
November 3 - 5, 2010 Ottawa, CanadaThe program will highlight information on improving efficiency in the running of clinical trials; discussion of streamlining federal and provincial regulatory and formulary approvals; and advice on strategies to overcome obstacles.
[More]
Cambridge Healthtech Institute’s and the BioPharma Strategy Series’ fifth annual executive forum Post-Approval Drug Safety Strategies
[More]
The program will focus on clinical risk assessment and bridging the gap between preclinical data and clinical studies and offer strategies to better assess, predict and mitigate safety risks.
[More]
Ensure Quality, Structure and Totality of Data Analysis throughout Development to Drive Risk Management Plans
[More]
FDA Risk Management / REMS Advisory Committee Meetings
Drug Safety and Risk Management Advisory Committee Meeting
September 14, 2010 University of MarylandThe committee will discuss the abuse potential of the drug dextromethorphan and the public health benefits and risks of dextromethorphan use as a cough suppressant in prescription and nonprescription drug products.
[More]
Previous page: In The News Next page: Press Releases